• Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects

There are no projects in the garbage can.

  • WebMail
  • Private area
  • Español
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • WebMail
  • Private area
  • Español

There are no projects in the garbage can.

International Projects

diaRNAgnosis

Home

diaRNAgnosis

diaRNAgnosis

GenE-Humdi – Genome Editing for the treatment of human Disease Network

GenE-Humdi – Genome Editing for the treatment of human Disease Network

Program SPARK THERAPUTICS INC

Program SPARK THERAPUTICS INC

3TR

3TR

Research

Publications

See more

The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination.

Authors: Tarriño M, Gutiérrez-Bautista JF, Durán MJO, Garcia-Diaz A, Cabrera-Serrano AJ, Sainz J, Cobo F, Rodriguez T, Reguera JA, Bernal M, López-Nevot MÁ, Sampedro A

07/2025 - Scientific reports

Bisphenol A exposure and behavioral outcomes in children: A systematic review and meta-analysis of evidence limited to the BASC assessment tool.

Authors: González-Palacios P, Ramírez V, Monteagudo C, Zafra-Gómez A, Rivas A

07/2025 - Neuroscience and biobehavioral reviews

Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.

Authors: López-Tejada A, Blaya-Cánovas JL, Cara FE, Calahorra J, Ramírez-Tortosa C, Blancas I, Delgado-Almenta V, Muñoz-Parra F, Ávalos-Moreno M, Sánchez A, González-González A, Marchal JA, Griñán-Lisón C, Granados-Principal S

06/2025 - International journal of biological sciences

    Transparency

  • Documents of interest
  • Organizational structure
  • Organizational chart

    Research

  • Research groups
  • Functional Genomics Area
  • Personalised Medicine Area
  • International Projects
  • Publications

    Center

  • What is GENyO?
  • Support Units
  • Management Units
  • Strategic Plan 2024-2027
  • Transparency
  • Contact

    Events and news

  • News
  • Events
  • Scientific Conferences
  • Galleries

Address

Avda. de la Ilustración 114.
18016 Granada, Spain

+34 958 715 500
info@genyo.es
  • Company affiliation

    2025 @Genyo All rights reserved

  • Legal note
  • Cookies Policy
  • Privacy Policy